An Israeli research and development company has released a request for a bone marrow donation, which will be used to produce innovative treatment for coronary patients

• Corona virus in close-up photography // Photo: IP

The brainstorm cell therapeutics-based drug research and development company has been recruited to assist hard-core coronary patients, and has issued a calling voice requesting bone marrow donations to be used to treat these patients. This is an innovative treatment that has already been tried in China, and the Chinese claim 100 percent success in rescuing patients who are severely ill by the drug.

The basis of the treatment came from an experimental result that made it clear that injected stem cells that have been specially treated into the human body have a very good effect on repairing serious lung damage. It is a drug that can save people who are severely injured by their breath. Corona disease, for example, produces pulmonary damage leading to a problem called acute respiratory distress syndrome. It is a failure that causes the death of 50-60 percent of patients. This failure, which is one of the symptoms and consequences of coronary disease in severely injured and critically endangered patients, is one of the major causes of mortality.

The company itself is engaged in the research of stem cell treatments worldwide and is traded on Nasdaq and is considered a leading research company in other fields. However, the new situation and the progress of the epidemic have harmed the company members working in Israel jointly with Ichilov Hospital in Tel Aviv on other issues, in an effort to raise bone marrow donations to carry out the innovative treatment of bone marrow injection.

It should be noted that this is a treatment claimed in China because it helps and that it has had very large successes, but that does not yet have extensive research evidence. In fact, had it not been for fear of large casualties in the Corona disease such trial and treatment for humans would not have been approved, despite reports of its successes. According to publications in the world, a tidy study will soon be published to learn about the success of the treatment.

Either way, the company posted the reading on its Facebook page and it reads: "Brainstorms hereby appeal to the public to volunteer and donate bone marrow for the production of breakthrough therapy designed to treat the coronary virus's severely ill patients. These days when the world is struggling with the corona virus, we at Brainstorm invest The greatest effort is made to present as many therapeutic alternatives as possible. The donation and medical care will be made at the Soraski Tel Aviv (Ichilov Hospital), subject to the approval of the Ministry of Health and in accordance with all the provisions of the law, paying attention to the provisions regarding compassionate treatment of experimental medical devices. Prerequisite: Israeli citizen aged 30-50, healthy without background disease. Applicants will have to undergo epidemiological questioning as well as a number of medical examinations.